Abstract: Biotinylated analogs of drug candidates provide useful tools for studying the drug-target protein interactions.
Introduction
The importance of adenosine monophosphate-activated kinase (AMPK) in regulating energy homeostasis 1−3 gives it a dominant role in cell maintenance and cell cycle progression and makes it an attractive target for new drugs to treat diseases such as obesity, diabetes, 4 and cancer. 5 Activated AMPK plays an essential role in various signaling pathways, important cellular processes that affect lipid, cholesterol, and glucose metabolism. The sequence of events in the activation of the heterotrimeric AMPK involves the initial binding of AMP at the 2 Bateman domains, each composed of 2 cystathione β -synthase subdomains in the γ subunit of AMPK ( Figure 1 ). The AMP-binding event triggers a conformational change in the γ subunit and permits phosphorylation of Thr142 in the associated α subunit. Unraveling the precise location where "small molecule" drug candidates bind AMPK is challenging because of various isoforms for each of the 3 subunits, the binding of various kinases (AMPKK) that phosphorylate AMPK, the binding of allosteric activators, and the numerous interacting partners of the activated AMPK. Any of these stages of activation and interaction are potential targets for therapeutic drugs, and a number of small-molecule activators are now known, including metformin, phenformin, aminoimidazole carboxamide ribonucleotide (AICAR), and A769662, that inhibit or delay tumor progression in animal models.
5
Understanding the nature of drug-target interactions at a molecular level is a common theme in modern drug discovery and makes use of several approaches including affinity chromatography. the covalently tethered biotin-drug complex retains biological activity, if the drug exhibits high affinity for the target protein(s), and if the tether between the drug and D-( +) -biotin is sufficient to accommodate binding of streptavidin and the target protein at each of the termini of the tethered biotin-drug complex ( Figure 2 ). Commercially available biotinylation reagents offer a range of tether lengths and chemical handles suitable for attachment to amines, alcohols, thiols, and carboxylate groups.
7 Although biotinylation is a versatile approach for affinity chromatography studies of drug-protein and protein-protein interactions, the best locus for the tethered biotin on a particular drug must be determined on a case-by-case basis. Recently, we reported that N,N'-diarylureas activated AMPK, 8 and we next sought to determine their binding target(s) using biotinylated derivatives.
Results and discussion
The addition of 4,5-dichloro-2-nitro, 4,5-difluoro-2-nitro-, 4-trifluoromethyl-2-nitroanilines (1a-c) to 4-trifluoromethylthiophenylisocyanate and stannous chloride reduction of the intermediate nitro compounds gave the polyhalogenated N,N'-diarylureas (2a-c) ( Figure 3) . In examining the best sites on the polyhalogenated N,N'-diarylureas where we could position a tethered biotin moiety, we were constrained by the limited number of unsubstituted positions on the aryl rings. We explored 2 sites for the tethered biotin: the C-2 position in the 4,5-dichloro-, 4,5-difluoro-, and 4-trifluoromethylaniline portion of the N,N'-diarylureas (3-7) or a carboxamide or sulfonamide group at the C-4 position of the N,N'-diarylureas (8 and 9). The goal of these studies was the development of a biologically active N,N'-diarylurea tethered to biotin using an appropriate spacer.
Synthesis of biotinylated N,N'-diarylureas
A structure-activity study 8 
AMPK activation of biotinylated N,N'-diarylureas
We previously demonstrated that N,N'-diarylureas activated AMPK by analyzing AMPK activation by Western blotting with anti-Phospho-AMPKa (Thr172). 8 The total amount of AMPK was analyzed as a control. We found that 4'-trifluoromethylthiophenyl-3,4-dichlorophenylurea significantly increased phosphorylated AMPK at 1-3 µ M concentrations. The biotinylated N,N'-diarylureas 3-9 ( Figure 3 ) were evaluated at 10 µM concentrations, but unfortunately they displayed considerably reduced potency relative to nonbiotinylated counterparts. For example, the biotinylated N,N'-diarylurea 3 showed no activation at 3 µ M and only 16% of the AMPK activation at 10 µ M that was displayed by its nonbiotinylated N,N'-diarylurea 2a at 3 µ M. As this level of AMPK activation was judged to be too little to proceed, the search for additional biotinylated versions of these promising reagents continues.
Experimental

Chemicals
Chemicals were purchased from Sigma Aldrich, Alfa Aesar, Quanta Biodesign, Ltd. (d-PEG R ⃝-4-biotin acid or 15-N-(+) -biotinamido-4,7,10,13-tetraoxopentadecanoic acid), and Thermo Scientific (amine-PEG 3 -biotin or (+) -biotinyl-3,6,9-trioxaundecanediamine), or the necessary chemicals were synthesized according to literature procedures. N,N'-Diarylureas were prepared as previously described. 8 Solvents were used from commercial vendors without further purification unless otherwise noted. Nuclear magnetic resonance spectra were determined in DMSO-d 6 using a Varian instrument ( 1 H, 400 MHz). The complexity of fluorine-carbon couplings in these polyfluorinated compounds provided little useful structural information and 13 C NMR data were not recorded.
MALDI mass spectra were obtained on a Bruker Ultraflexstreme time-of-flight mass spectrometer (Billerica, MA, USA), using DHB (2,5-dihydroxybenzoic acid) matrix. Compounds were chromatographed on preparative layer Merck silica gel F254 unless otherwise indicated.
General procedures for the synthesis of biotinylated ureas
To 
5-(2-Oxohexahydro-1H -thieno[3,4-d ]imidazol-4-yl)-N -(5-(trifluoromethyl)-2-(3-(4-(trifluo-
romethylthio
1-(5-(2-Oxohexahydro-1H -thieno[3,4-d ]imidazol-4-yl)pentanamido)-N -(5-(trifluoromethyl)-
2-(3-(4-(trifluoromethylthio)phenyl)ureido)phenyl)-3,6,9,12-tetraoxapentadecan-15-amide (7).
Yield 18% as white solid (1: 
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